NYSE : THC
Tenet Healthcare Corporation — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 270.57 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 21.79B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 21.75B |
| Enterprise Value | 32.32B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 79.59M |
| Shares Outstanding | 79.59M |
| Shares Change (YoY) | -8.43% |
| Shares Change (QoQ) | -4.01% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 100.62% |
| Float | 79.68M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 8.01 |
| Forward PE | 13.16 |
| PS Ratio | 0.98 |
| Forward PS | 0.97 |
| PB Ratio | 3.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.53 |
| P/OCF Ratio | 5.13 |
| PEG Ratio | 1.57 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 11.15 |
| EV / Sales | 1.46 |
| EV / EBITDA | 6.30 |
| EV / EBIT | 7.63 |
| EV / FCF | 9.71 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.58 |
| Quick Ratio | 1.28 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 2.39 |
| Debt / FCF | 3.98 |
| Interest Coverage | 5.18 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 41.70% |
| Return on Assets (ROA) | 8.68% |
| Return on Invested Capital (ROIC) | 17.09% |
| Return on Capital Employed (ROCE) | 16.12% |
| Weighted Average Cost of Capital (WACC) | 8.62% |
| Revenue Per Employee | $223,778 |
| Profits Per Employee | $29,283 |
| Employee Count | 99,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 37.16 |
Taxes
| Measure | Value |
|---|
| Income Tax | 918.00M |
| Effective Tax Rate | 19.40% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +30.65% |
| 50-Day Moving Average | 264.87 |
| 200-Day Moving Average | 220.21 |
| Relative Strength Index (RSI) | 58.16 |
| Average Volume (20 Days) | 697,176 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.84M |
| Short Previous Month | 2.02M |
| Short % of Shares Out | 2.31% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 2.63 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 22.15B |
| Gross Profit | 9.41B |
| Operating Income | 4.24B |
| Pretax Income | 4.73B |
| Net Income | 2.90B |
| EBITDA | 5.13B |
| EBIT | 4.24B |
| Earnings Per Share (EPS) | $34.11 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.67B |
| Total Debt | 13.24B |
| Net Cash | -10.57B |
| Net Cash Per Share | -$132.80 |
| Equity (Book Value) | 9.59B |
| Book Value Per Share | 68.41 |
| Working Capital | 3.11B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 4.24B |
| Capital Expenditures | -910.00M |
| Depreciation & Amortization | 892.00M |
| Net Borrowing | -73.00M |
| Free Cash Flow | 3.33B |
| FCF Per Share | $41.82 |
Margins
| Measure | Value |
|---|
| Gross Margin | 42.47% |
| Operating Margin | 19.12% |
| Pretax Margin | 21.36% |
| Profit Margin | 13.09% |
| EBITDA Margin | 23.14% |
| EBIT Margin | 19.12% |
| FCF Margin | 15.02% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 8.43% |
| Shareholder Yield | 8.43% |
| Earnings Yield | 12.48% |
| FCF Yield | 15.30% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $298.82 |
| Price Target Difference | 9.36% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 3.42% |
| EPS Growth Forecast (3Y) | 11.07% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |